Valuation (90%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.65 | N/A |
| PEG Ratio (TTM) | 0.35 | N/A |
| P/S Ratio (TTM) | 2.34 | N/A |
| P/B Ratio (TTM) | 1.35 | N/A |
| P/FCF Ratio (TTM) | 12.47 | N/A |
| Price to 5YR AVG Earnings Ratio | 7.90 | N/A |
| Price to 5YR AVG FCF Ratio | 6.97 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.71% | N/A |
| ROE (TTM) | 10.38% | N/A |
| Net Profit Margin (TTM) | 17.17% | N/A |
| ROIC 5YR AVG | 21.43% | N/A |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 134.52% | -11.15% | 1.13% |
| Revenue | -0.44% | -5.98% | -5.72% |
| Net Income | 134.78% | -20.09% | -5.27% |
| Cash Flow | 1,072.59% | -13.27% | -18.00% |
Health (60%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.26 | N/A |
| Quick Ratio (TTM) | 0.80 | N/A |
| D/E Ratio (TTM) | 0.38 | N/A |
| Interest Coverage (TTM) | 7.59 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.69 | N/A |
| LTL to 5YR AVG FCF | 2.27 | N/A |
| Shares Outstanding Growth 5YR AVG | -6.60% | N/A |